Upgrade to SI Premium - Free Trial

Dow Reports Fourth Quarter and Full-Year Results

January 26, 2017 6:45 AM

MIDLAND, Mich.--(BUSINESS WIRE)-- The Dow Chemical Company (NYSE: DOW):

Fourth Quarter 2016 Highlights

Comment

Andrew Liveris, Dow’s chairman and chief executive officer, stated:

“This was another strong quarter for our company, extending our streak of year-over-year earnings and volume growth – reaching 17 consecutive quarters of increases in operating EPS and 13 consecutive quarters of volume growth. We delivered record quarterly and full-year operating EBITDA and generated strong cash flow from operations of $1.9 billion in the quarter. And this year we returned nearly $3 billion to our owners through share repurchases and the highest annual dividend in our history.

“Operationally, we showcased the power and resilience of our consumer-driven business model throughout the year, no matter what economic volatility occurred. By capitalizing on our market focus and innovation launches, we delivered full-year operating EBITDA records in multiple downstream businesses, including Automotive Systems, Building & Construction, Electronic Materials and Dow AgroSciences.

“Strategically, we advanced our growth investments. Sadara completed construction of its world-scale site, celebrated startups of its largest units and began ramping production of its 26 operating units. On the U.S. Gulf Coast, we completed capacity expansions in Louisiana and Texas. And we accelerated the integration of Dow Corning silicones, surpassing all of our value and synergy capture targets and capitalizing on the business’s natural fit within Dow’s portfolio.

“Simply put, the Dow team continues to deliver a consistent track record of executing against our priorities, proving time and again the resilience and agility of our focused business model, which performs under all economic conditions.”

2016 Full-Year Highlights

Three Months Ended
Dec 31, Dec 31,
In millions, except per share amounts 2016 2015
Net Sales $13,020 $11,462
Adjusted Sales(5) $11,749 $11,462
Net Income (Loss) Available for Common Stockholders $(33) $3,527
Net Income Available for Common Stockholders,

Excluding Certain Items

$1,121 $1,057
Earnings (Loss) per Common Share – Diluted $(0.03) $2.94
Operating Earnings per Share $0.99 $0.93
Twelve Months Ended
Dec 31, Dec 31,
In millions, except per share amounts 2016 2015
Net Sales $48,158 $48,778
Adjusted Sales(5) $45,108 $46,672
Net Income Available for Common Stockholders $3,978 $7,345
Net Income Available for Common Stockholders,

Excluding Certain Items

$4,221 $4,054
Earnings per Common Share – Diluted $3.52 $6.15
Operating Earnings Per Share $3.72 $3.47

Agricultural Sciences

Agricultural Sciences reported fourth quarter sales of $1.7 billion, up from $1.6 billion, an increase of 7 percent versus the year-ago period. Volume rose 5 percent and price increased 2 percent.

Volume gains were achieved in both Crop Protection and Seeds. Crop Protection volume growth was driven by double-digit gains in Latin America herbicides and EMEAI insecticides. Seeds demand rose primarily driven by double-digit corn seed gains in Latin America and North America, partially offset by lower sunflower seed demand in Latin America. Pricing gains reflected a double-digit increase in Seeds, driven by local price and currency improvements, partially offset by lower Crop Protection chemical prices. The business reported robust sales of new Crop Protection products in the quarter (up 73 percent) led by Arylex™ herbicide and Isoclast™ insecticide.

EBITDA for the segment decreased to $74 million from $186 million in the year-ago period as a result of the partial impairment of Dow’s investment in AgroFresh. Operating EBITDA rose to a fourth quarter record of $239 million. This compares with operating EBITDA of $220 million in the year-ago period, which benefited from the sale of several non-strategic molecules. The year-over-year increase was primarily driven by double-digit growth in both price and volume for corn seeds; favorable currency impacts; robust sales of new crop protection product technologies; and the business’s continued focus on self-help productivity actions.

Equity losses for the segment were $1 million, an improvement compared to losses of $17 million in the year-ago period.

Consumer Solutions

Consumer Solutions reported fourth quarter sales of $1.6 billion, up from $1.1 billion in the year-ago period, primarily reflecting the contribution of Consumer Solutions – Silicones. Sales gains in all business were driven by broad-based volume growth, more than offsetting a modest 2 percent price decline in the segment. Volume increased 50 percent, driven by the addition of Consumer Solutions – Silicones, which reported strong demand led by Asia Pacific, for automotive applications.

Excluding acquisitions, segment volume grew 7 percent, with broad-based gains across all businesses and double-digit growth in Asia Pacific and Latin America. Dow Automotive Systems gained share and further diversified its customer base, driving double-digit volume growth in Greater China and Brazil as the business continues to outpace the global automotive end-market’s expansion. Consumer Care delivered double-digit volume gains in North America and Latin America on share growth in detergents and on new product introductions supporting trends in gluten-free foods. Dow Electronic Materials continued its above-market volume growth as new business wins yielded double-digit increases in semiconductor and display technologies.

EBITDA for the segment was an all-time record of $568 million. Operating EBITDA rose to an all-time quarterly record of $541 million, up significantly from $296 million in the year-ago period. The increase in operating EBITDA reflects the contribution from Consumer Solutions – Silicones, new commercial wins and market share gains.

Equity earnings for the segment were $85 million, compared to $38 million in the year-ago period on strong sales at the HSC Group.

Infrastructure Solutions

Infrastructure Solutions reported fourth quarter sales of $2.4 billion, up from $1.7 billion in the year-ago period, reflecting the addition of Infrastructure Solutions – Silicones. Segment volume increased 43 percent, primarily due to the addition of Infrastructure Solutions – Silicones, which reported strong demand in Asia Pacific and EMEAI for base silicones used in a variety of building and construction, coatings and energy applications. The segment reported a modest 2 percent decline in pricing.

Excluding acquisitions, the segment volume declined 5 percent. Dow Building & Construction delivered volume growth on double-digit gains for cellulosics-based construction chemicals. Dow Coating Materials achieved a volume increase, led by gains in both the architectural and industrial market sectors, including strong growth in Asia Pacific. Energy & Water Solutions reported a volume decline on reduced year-over-year project activity in water market sectors and lower demand in refining and processing end-markets. Performance Monomers reported a volume decline due to planned maintenance activity and the business’s ongoing strategy to reduce its merchant acrylic monomer exposure.

Reported and Operating EBITDA for the segment were $350 million versus reported EBITDA of $161 million and operating EBITDA of $235 million in the year-ago period. The contribution of Infrastructure Solutions – Silicones more than offset the impact of planned maintenance activity in the acrylics chain and the soft industry fundamentals impacting Energy & Water Solutions.

Equity earnings for the segment were $94 million, compared to $67 million in the year-ago period on strong sales at the HSC Group.

Performance Materials & Chemicals

Performance Materials & Chemicals reported fourth quarter sales of $2.41 billion, slightly up from $2.38 billion in the year-ago period.

Volume increased 3 percent with gains in most geographic areas led by robust growth in Asia Pacific. Polyurethanes volume grew year-over-year for the fifteenth consecutive quarter led by a double-digit increase in demand for downstream, higher-margin systems applications. Industrial Solutions volume rose due to a double-digit demand increase in Asia Pacific, particularly on strength in Greater China, which more than offset looser market conditions in EMEAI. Chlor-Alkali and Vinyl volume increased on steady demand for vinyl chloride monomer and caustic soda in EMEAI.

EBITDA was $411 million. This compares with EBITDA of $3.1 billion in the same period last year, which reflected a gain from the split-off of Dow Chlorine Products and the sale of Dow’s direct ownership interest in MEGlobal. Operating EBITDA was $412 million, down from $423 million in the same period last year, primarily driven by pricing pressures that resulted in margin compression, which more than offset improved equity earnings.

Equity earnings for the segment were $31 million, an improvement versus equity losses of $6 million in the same quarter last year on higher earnings from the Kuwait joint ventures, primarily due to improved monoethylene glycol pricing, and a higher contribution from one of the Company’s joint ventures in Thailand.

Performance Plastics

Performance Plastics reported fourth quarter sales of $4.8 billion, up from $4.6 billion in the year-ago period, with gains in all businesses except for Dow Electrical and Telecommunications.

The segment reported volume growth of 4 percent. Dow Packaging and Specialty Plastics achieved a quarterly and full-year sales volume record on ramping Sadara production, which contributed to double-digit growth in Greater China. Dow Elastomers also achieved a quarterly and full-year sales volume record, led by double-digit demand growth in both Asia Pacific and EMEAI, propelled by automotive and footwear end-markets. Dow Electrical and Telecommunications volume declined as a result of planned maintenance activity in the quarter.

EBITDA for the segment was $1 billion. This compares with EBITDA of $1.6 billion in the same period last year, which included a gain from the split-off of Dow Chlorine Products. Operating EBITDA for the segment was $1.1 billion, down from a fourth quarter record of $1.3 billion in the year-ago period, on increased feedstock and energy costs and planned maintenance activity.

Equity earnings for the segment were $54 million, an increase from $46 million in the same quarter last year.

Outlook

Commenting on the Company’s outlook, Liveris said:

“We are seeing early signs of positive economic momentum, with the United States in expansionary mode, driven by the ongoing strength of the consumer and the tailwind of a new incoming administration promising structural reforms. Europe continues its gradual recovery, despite increasing political uncertainty and geopolitical tensions. China’s transition is progressing on a robust path, and sustained growth of Asia’s middle class continues to drive demand throughout the region. And finally, we see improvement in Latin America from its low base, with slow but stable gains continuing in Brazil.

“We expect demand for Dow’s portfolio to remain healthy, particularly in the businesses that serve packaging, infrastructure, consumer care, electronics, automotive and agriculture. Building on our strong achievements these past several years, we remain well-positioned to capture growth where growth exists around the world. And our strategic investments – Sadara, Dow Corning and the U.S. Gulf Coast projects – will deliver the next layers of integration strength, earnings growth and cash flow generation.

“The portfolio has been positioned such that delivering stable EPS and EBITDA growth has become our mantra. Over the last four years we have delivered annual EPS growth of 18 percent and annual EBITDA growth of 7 percent. For the year ahead, we remain squarely focused on three priorities: achieving our financial and operating plan; closing the DowDuPont transaction and driving quickly toward the intended spins; and capitalizing on our strategic growth projects. We will continue to deliver strong financial performance for our customers and our shareholders.”

Dow will host a live webcast of its fourth quarter and full-year earnings conference call with investors to discuss its results, business outlook and other matters today at 9:00 a.m. ET on www.dow.com.

(1) Operating earnings per share is defined as earnings per share excluding the impact of “Certain Items.” See Supplemental Information at the end of the release for a description of these items, as well as a reconciliation of ‘Operating earnings per common share – diluted” to “Earnings per common share – diluted.”
(2) EBITDA is defined as earnings (i.e., “Net Income (Loss)”) before interest, income taxes, depreciation and amortization. A reconciliation of EBITDA to "Net Income (Loss) Available for The Dow Chemical Company Common Stockholders" is provided following the Operating Segments table. Operating EBITDA is defined as EBITDA excluding the impact of “Certain Items.”
(3) EBITDA margin is defined as EBITDA as a percentage of reported net sales.
(4) Operating EBITDA margin is defined as Operating EBITDA as a percentage of reported net sales.
(5) “Adjusted Sales” is defined as “Net Sales” adjusted for divestitures and acquisitions.
™Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow.

About Dow

Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems, such as the need for fresh food, safer and more sustainable transportation, clean water, energy efficiency, more durable infrastructure, and increasing agricultural productivity. Dow's integrated, market-driven portfolio delivers a broad range of technology-based products and solutions to customers in 175 countries and in high-growth sectors such as packaging, infrastructure, transportation, consumer care, electronics, and agriculture. In 2016, Dow had annual sales of $48 billion and employed approximately 56,000 people worldwide. The Company's more than 7,000 product families are manufactured at 189 sites in 34 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.

Use of non-GAAP measures: Dow’s management believes that measures of income excluding certain items (“non-GAAP” measures) provide relevant and meaningful information to investors about the ongoing operating results of the Company. Such measurements are not recognized in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP measures are provided in the Supplemental Information tables.

Note: The forward looking statements contained in this document involve risks and uncertainties that may affect Dow’s operations, markets, products, services, prices and other factors as discussed in filings with the Securities and Exchange Commission (“SEC”). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that Dow’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Financial Statements (Note A)

The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
Three Months Ended Twelve Months Ended
In millions, except per share amounts (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Net Sales $ 13,020 $ 11,462 $ 48,158 $ 48,778
Cost of sales (Note B) 10,574 8,806 37,641 37,836
Research and development expenses 425 404 1,584 1,598
Selling, general and administrative expenses (Note C) 911 757 3,304 2,971
Amortization of intangibles 157 103 544 419
Restructuring charges (Note D) 40 452 415
Asbestos-related charge (Note E) 1,113 1,113
Equity in earnings of nonconsolidated affiliates (Note F) 251 99 442 674
Sundry income (expense) - net (Note G) (103 ) 2,912 1,202 4,592
Interest income 43 25 107 71
Interest expense and amortization of debt discount 229 240 858 946
Income (Loss) Before Income Taxes (198 ) 4,148 4,413 9,930
Provision (Credit) for income taxes (Note H) (282 ) 517 9 2,147
Net Income 84 3,631 4,404 7,783
Net income attributable to noncontrolling interests 32 19 86 98
Net Income Attributable to The Dow Chemical Company 52 3,612 4,318 7,685
Preferred stock dividends 85 85 340 340
Net Income (Loss) Available for The Dow Chemical Company Common Stockholders $ (33 ) $ 3,527 $ 3,978 $ 7,345
Per Common Share Data:
Earnings (Loss) per common share - basic $ (0.03 ) $ 3.17 $ 3.57 $ 6.45
Earnings (Loss) per common share - diluted (Note I) $ (0.03 ) $ 2.94 $ 3.52 $ 6.15
Dividends declared per share of common stock $ 0.46 $ 0.46 $ 1.84 $ 1.72
Weighted-average common shares outstanding - basic 1,106.2 1,105.4 1,108.1 1,130.1
Weighted-average common shares outstanding - diluted (Note I) 1,106.2 1,218.9 1,123.2 1,241.4
Depreciation $ 590 $ 446 $ 2,130 $ 1,909
Capital Expenditures $ 927 $ 886 $ 3,804 $ 3,703

Notes to the Consolidated Financial Statements:

Note A: The unaudited consolidated financial statements reflect all adjustments which, in the opinion of management, are considered necessary for a fair presentation of the results for the periods covered. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. Except as otherwise indicated by the context, the terms "Company" and "Dow" as used herein mean The Dow Chemical Company and its consolidated subsidiaries.

Note B: In the fourth quarter of 2016, the Company recognized pretax charges of $295 million for environmental matters and $117 million for the termination of a terminal use agreement. Also in the fourth quarter of 2016, the Company recognized pretax charges of $39 million for costs associated with transactions and productivity actions ($28 million in the third quarter of 2016, $34 million in the second quarter of 2016 and $23 million in the first quarter of 2016). In the third quarter of 2016, the Company recognized a pretax loss of $212 million associated with the fair value step-up in inventories assumed in the Dow Corning Corporation ("Dow Corning") ownership restructure ($105 million in the second quarter of 2016).

In the fourth quarter of 2015, the Company recognized pretax charges of $91 million for asset impairments and related costs. Also in the fourth quarter of 2015, the Company recognized pretax charges of $18 million for costs associated with transactions and productivity actions ($6 million in the third quarter of 2015). In the second quarter of 2015, the Company recognized a pretax loss of $12 million associated with the fair value step-up in inventories assumed in the Univation Technologies, LLC ("Univation") step acquisition.

Note C: In the fourth quarter of 2016, the Company recognized pretax charges of $129 million for costs associated with transactions and productivity actions ($135 million in the third quarter of 2016, $73 million in the second quarter of 2016 and $42 million in the first quarter of 2016). In the fourth quarter of 2015, the Company recognized pretax charges of $35 million for costs associated with transactions and productivity actions ($10 million in the third quarter of 2015 and $6 million in the second quarter of 2015).

Note D: On June 27, 2016, Dow's Board of Directors approved a restructuring plan that incorporates actions related to the recent ownership restructure of Dow Corning. These actions, aligned with Dow’s value growth and synergy targets, will result in a global workforce reduction of approximately 2,500 positions, with most of these positions resulting from synergies related to the Dow Corning transaction. As a result, the Company recorded pretax restructuring charges of $449 million in the second quarter of 2016 consisting of severance charges, asset write-downs and write-offs, and costs associated with exit and disposal activities.

On April 29, 2015, Dow's Board of Directors approved actions to further streamline the organization and optimize the Company’s footprint as a result of the separation of a significant portion of Dow’s chlorine value chain. These actions, which will further accelerate Dow’s value growth and productivity targets, will result in a reduction of approximately 1,750 positions across a number of businesses and functions and adjustments to the Company's asset footprint to enhance competitiveness. As a result, the Company recorded pretax restructuring charges of $375 million in the second quarter of 2015, which included asset write-downs and write-offs, severance charges and costs associated with exit and disposal activities. In the fourth quarter of 2015, the Company recorded additional pretax restructuring charges of $40 million, primarily related to severance costs for approximately 450 additional positions.

In the second quarter of 2016, the Company recorded a pretax charge of $5 million related to adjustments to the Company's 2015 restructuring program.

Note E: In the fourth quarter of 2016, the Company elected to change its method of accounting for asbestos-related defense costs from expensing as incurred to estimating and accruing a liability. As a result of this accounting policy change, the Company recorded a pretax charge of $1,009 million for asbestos-related defense costs through the terminal date of 2049. The Company also recorded a pretax charge of $104 million to increase the asbestos-related liability for pending and future claims through the terminal date of 2049.

Note F: In the second quarter of 2016, the Company recognized a loss of $22 million related to a loss on the early redemption of debt incurred by Dow Corning.

In the fourth quarter of 2015, the Company recognized a loss of $36 million related to actions taken by the Company's joint ventures including: a $20 million credit related to Dow Corning's adjustment of its implant liability, a $29 million charge related to AgroFresh Solutions Inc's ("AFSI") fair value step-up of its inventories and start-up costs, and a $27 million charge related to Sadara Chemical Company's ("Sadara") write-off of design engineering work for an Epoxy plant.

Note G: In the fourth quarter of 2016, the Company recognized a charge of $163 million related to AgroFresh and a pretax credit of $27 million related to a decrease in Dow Corning's implant liability. Also in the fourth quarter of 2016, the Company recognized a pretax charge of $8 million for a retained litigation matter related to the chlorine value chain ($33 million in the third quarter of 2016). In the second quarter of 2016, the Company recognized a pretax gain of $2,445 million on the Dow Corning ownership restructure and a pretax gain of $6 million related to post-closing adjustments on the split-off of the chlorine value chain. In the first quarter of 2016, the Company recognized a pretax loss of $1,235 million related to the settlement of the urethane matters class action lawsuit and opt-out cases.

In the fourth quarter of 2015, the Company recognized a pretax gain of $2,233 million (after-tax gain of $2,215 million) on the split-off of the chlorine value chain; a $723 million pretax gain related to the sale of MEGlobal; an $11 million pretax gain for post closing and other adjustments related to 2015 business divestitures; a pretax charge of $98 million related to the December 2015 devaluation of the Argentine Peso; a pretax charge of $53 million related to the impairment of an equity method investment; a pretax loss of $8 million on the early extinguishment of debt; and a pretax charge of $15 million related to transactions and productivity actions.

In the third quarter of 2015, the Company recognized a pretax gain of $621 million related to the divestiture of the AgroFresh business and pretax charges of $35 million for costs associated with transactions and productivity actions ($43 million in the second quarter of 2015 and $26 million in the first quarter of 2015). In the second quarter of 2015, the Company recognized a pretax gain of $361 million related to the Univation step acquisition. In the first quarter of 2015, the Company recognized a pretax gain of $670 million related to the divestiture of ANGUS Chemical Company ("ANGUS") and a pretax gain of $18 million related to the divestiture of the Sodium Borohydride business.

Note H: In the second quarter of 2016, the Company recognized a tax charge of $57 million for the adjustment of an uncertain tax position associated with a historical change in the legal ownership structure of a nonconsolidated affiliate. A tax benefit of $44 million was recognized in the fourth quarter of 2016 relating to the settlement of the matter.

Note I: On December 30, 2016, the Company converted 4 million shares of the Company's Cumulative Convertible Perpetual Preferred Stock, Series A ("Preferred Stock") into 96.8 million shares of the Company's common stock. See Supplemental Information for further details on how this transaction impacted "Weighted average common shares outstanding - basic" and "Weighted average common shares outstanding - diluted" for the three- and twelve-month periods ended December 31, 2016.

"Earnings (Loss) per common share - diluted" for the three-month period ending December 31, 2016 was calculated using "Weighted average common shares outstanding - basic" due to a net loss reported in the period.

"Earnings per common share - diluted" for the three-month period ended December 31, 2015 and twelve-month period ended December 31, 2015, assumes the conversion of the Company's Preferred Stock into potential shares of the Company's common stock due to the net income reported for these periods, which includes the after-tax gain on the divestitures of AgroFresh and ANGUS and the after-tax gain on the Univation step acquisition. In accordance with U.S. GAAP, "Weighted-average common shares outstanding - diluted" increased by 96.8 million shares and "Net Income Attributable to The Dow Chemical Company" was used in the calculation of "Earning per common share - diluted" for the three and twelve month periods ended December 31, 2015.

The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
Dec 31, Dec 31,
In millions (Unaudited) 2016 2015
Assets
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2016: $75; 2015: $158) $ 6,607 $ 8,577
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2016: $110; 2015: $94) 4,666 4,078
Other 4,358 3,768
Inventories 7,363 6,871
Other current assets 665 647
Total current assets 23,659 23,941
Investments
Investment in nonconsolidated affiliates 3,747 3,958
Other investments (investments carried at fair value - 2016: $1,959; 2015: $1,866) 2,969 2,923
Noncurrent receivables 708 816
Total investments 7,424 7,697
Property
Property 57,438 50,802
Less accumulated depreciation 33,952 32,948
Net property (variable interest entities restricted - 2016: $961; 2015: $1,717) 23,486 17,854
Other Assets
Goodwill 15,272 12,154
Other intangible assets (net of accumulated amortization - 2016: $4,295; 2015: $3,770) 6,026 3,617
Deferred income tax assets 3,079 2,140
Deferred charges and other assets 565 535
Total other assets 24,942 18,446
Total Assets $ 79,511 $ 67,938
Liabilities and Equity
Current Liabilities
Notes payable $ 272 $ 454
Long-term debt due within one year 635 541
Accounts payable:
Trade 4,519 3,577
Other 2,401 2,287
Income taxes payable 600 452
Dividends payable 508 592
Accrued and other current liabilities 3,669 3,212
Total current liabilities 12,604 11,115
Long-Term Debt (variable interest entities nonrecourse - 2016: $330; 2015: $487) 20,456 16,215
Other Noncurrent Liabilities
Deferred income tax liabilities 923 587
Pension and other postretirement benefits - noncurrent 11,375 9,119
Asbestos-related liabilities - noncurrent 1,364 387
Other noncurrent obligations 5,560 4,332
Total other noncurrent liabilities 19,222 14,425
Stockholders’ Equity
Preferred stock, series A 4,000
Common stock 3,107 3,107
Additional paid-in capital 4,262 4,936
Retained earnings 30,338 28,425
Accumulated other comprehensive loss (9,822 ) (8,667 )
Unearned ESOP shares (239 ) (272 )
Treasury stock at cost (1,659 ) (6,155 )
The Dow Chemical Company’s stockholders’ equity 25,987 25,374
Noncontrolling interests 1,242 809
Total equity 27,229 26,183
Total Liabilities and Equity $ 79,511 $ 67,938

See Notes to the Consolidated Financial Statements.

The Dow Chemical Company and Subsidiaries

Operating Segments

Three Months Ended Twelve Months Ended
In millions (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Sales by operating segment
Agricultural Sciences $ 1,716 $ 1,603 $ 6,174 $ 6,381
Consumer Solutions 1,561 1,052 5,455 4,379
Infrastructure Solutions 2,408 1,705 8,621 7,394
Performance Materials & Chemicals 2,413 2,381 9,225 11,973
Performance Plastics 4,843 4,617 18,404 18,357
Corporate 79 104 279 294
Total $ 13,020 $ 11,462 $ 48,158 $ 48,778
EBITDA (1) by operating segment
Agricultural Sciences $ 74 $ 186 $ 806 $ 1,432
Consumer Solutions 568 304 2,828 1,048
Infrastructure Solutions 350 161 2,318 1,021
Performance Materials & Chemicals 411 3,144 134 5,479
Performance Plastics 1,024 1,562 4,503 5,399
Corporate (1,644 ) (394 ) (2,563 ) (1,053 )
Total $ 783 $ 4,963 $ 8,026 $ 13,326
Certain items (increasing) decreasing EBITDA by operating segment (2)
Agricultural Sciences $ (165 ) $ (34 ) $ (170 ) $ 573
Consumer Solutions 27 8 1,144 (59 )
Infrastructure Solutions (74 ) 864 (101 )
Performance Materials & Chemicals (1 ) 2,721 (1,230 ) 3,409
Performance Plastics (119 ) 260 (129 ) 597
Corporate (1,579 ) (308 ) (2,261 ) (689 )
Total $ (1,837 ) $ 2,573 $ (1,782 ) $ 3,730
EBITDA excluding certain items by operating segment
Agricultural Sciences $ 239 $ 220 $ 976 $ 859
Consumer Solutions 541 296 1,684 1,107
Infrastructure Solutions 350 235 1,454 1,122
Performance Materials & Chemicals 412 423 1,364 2,070
Performance Plastics 1,143 1,302 4,632 4,802
Corporate (65 ) (86 ) (302 ) (364 )
Total $ 2,620 $ 2,390 $ 9,808 $ 9,596

Continued

The Dow Chemical Company and Subsidiaries
Operating Segments (Continued)
Three Months Ended Twelve Months Ended
In millions (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Equity in earnings (losses) of nonconsolidated affiliates by operating segment (included in EBITDA)
Agricultural Sciences $ (1 ) $ (17 ) $ 3 $ (15 )
Consumer Solutions 85 38 132 91
Infrastructure Solutions 94 67 215 203
Performance Materials & Chemicals 31 (6 ) (18 ) 225
Performance Plastics 54 46 137 220
Corporate (12 ) (29 ) (27 ) (50 )
Total $ 251 $ 99 $ 442 $ 674
(1) The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of "Net Income (Loss) Available for The Dow Chemical Company Common Stockholders" to EBITDA is provided below.
Reconciliation of "Net Income (Loss) Available for The Dow Chemical Company Common Stockholders" to EBITDA Three Months Ended Twelve Months Ended
In millions (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Net Income (Loss) Available for The Dow Chemical Company Common Stockholders $ (33 ) $ 3,527 $ 3,978 $ 7,345
+ Preferred stock dividends 85 85 340 340
+ Net income attributable to noncontrolling interests 32 19 86 98
+ Provision (Credit) for income taxes (282 ) 517 9 2,147
Income (Loss) Before Income Taxes $ (198 ) $ 4,148 $ 4,413 $ 9,930
+ Interest expense and amortization of debt discount 229 240 858 946
- Interest income 43 25 107 71
+ Depreciation and amortization 795 600 2,862 2,521
EBITDA $ 783 $ 4,963 $ 8,026 $ 13,326
(2) See Supplemental Information for a description of certain items affecting results in 2016 and 2015.

Sales by Geographic Area

Three Months Ended Twelve Months Ended
In millions (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
North America $ 4,717 $ 4,215 $ 18,083 $ 18,396
Europe, Middle East, Africa and India 3,680 3,420 14,667 15,291
Asia Pacific 2,764 2,017 9,129 8,308
Latin America 1,859 1,810 6,279 6,783
Total $ 13,020 $ 11,462 $ 48,158 $ 48,778
The Dow Chemical Company and Subsidiaries
Sales Volume and Price by Operating Segment and Geographic Area
Three Months Ended Twelve Months Ended
Dec 31, 2016 Dec 31, 2016
Percentage change from prior year Volume Price Total Volume Price Total
Agricultural Sciences 5 % 2 % 7 % (3 )% % (3 )%
Consumer Solutions 50 (2 ) 48 29 (4 ) 25
Infrastructure Solutions 43 (2 ) 41 23 (6 ) 17
Performance Materials & Chemicals 3 (2 ) 1 (14 ) (9 ) (23 )
Performance Plastics 4 1 5 8 (8 )
Total 14 % % 14 % 5 % (6 )% (1 )%
North America 11 % 1 % 12 % 5 % (7 )% (2 )%
Europe, Middle East, Africa and India 9 (2 ) 7 3 (7 ) (4 )
Asia Pacific 38 (1 ) 37 16 (6 ) 10
Latin America 2 1 3 (1 ) (6 ) (7 )
Developed geographies 11 % % 11 % 4 % (7 )% (3 )%
Emerging geographies (1) 18 (1 ) 17 8 (7 ) 1
Sales Volume and Price by Operating Segment and Geographic Area,

Excluding Acquisitions and Divestitures (2)

Three Months Ended Twelve Months Ended
Dec 31, 2016 Dec 31, 2016
Percentage change from prior year Volume Price Total Volume Price Total
Agricultural Sciences 5 % 2 % 7 % (2 )% % (2 )%
Consumer Solutions 7 (2 ) 5 4 (4 )
Infrastructure Solutions (5 ) (2 ) (7 ) (3 ) (6 ) (9 )
Performance Materials & Chemicals 3 (2 ) 1 2 (11 ) (9 )
Performance Plastics 4 1 5 9 (8 ) 1
Total 3 % % 3 % 4 % (7 )% (3 )%
North America 1 % 1 % 2 % 3 % (7 )% (4 )%
Europe, Middle East, Africa and India 1 (2 ) (1 ) 4 (8 ) (4 )
Asia Pacific 12 (1 ) 11 6 (6 )
Latin America (1 ) (1 ) (6 ) (6 )
Developed geographies 1 % % 1 % 3 % (7 )% (4 )%
Emerging geographies (1) 6 (1 ) 5 4 (7 ) (3 )
(1) Emerging geographies includes Eastern Europe, Middle East, Africa, India, Latin America and Asia Pacific excluding Australia, Japan and New Zealand.
(2) Excludes prior period sales of recent divestitures including the chlorine value chain, divested on October 5, 2015 (primarily Performance Materials & Chemicals and Performance Plastics); the AgroFresh business, divested on July 31, 2015 (Agricultural Sciences); ANGUS, divested on February 2, 2015 (Performance Materials & Chemicals); and the global Sodium Borohydride business, divested on January 30, 2015 (Performance Materials & Chemicals). Also excludes current period sales related to the ownership restructure of Dow Corning announced on June 1, 2016 (Consumer Solutions and Infrastructure Solutions) and sales from January 1, 2016 through April 30, 2016 for the step acquisition of Univation, acquired on May 5, 2015 (Performance Plastics).

Supplemental Information

Description of Certain Items Affecting Results

The following table summarizes the impact of certain items recorded in the three-month periods ended December 31, 2016 and December 31, 2015:
Certain Items Impacting Results Pretax Impact (1) Net Income (2) EPS - Diluted (3) (4) (5)
Three Months Ended Three Months Ended Three Months Ended
In millions, except per share amounts (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Reported U.S. GAAP Amounts (6) $ (33 ) $ 3,527 $ (0.03 ) $ 2.94
- Certain items:
Environmental charges $ (295 ) $ (205 ) (0.17 )
Charge for the termination of a terminal use agreement (117 ) (74 ) (0.06 )
Asset impairments and related costs (144 ) (123 ) (0.11 )
2015 Restructuring charges (40 ) (28 ) (0.03 )
Asbestos-related charge (1,113 ) (701 ) (0.58 )
Joint venture actions (36 ) (26 ) (0.02 )
Implant liability adjustment 27 17 0.01
Charges related to AgroFresh (163 ) (103 ) (0.08 )
Gain on split-off of chlorine value chain 2,233 2,215 1.96
Gain on sale of MEGlobal 723 589 0.52
Gain on 2015 business divestitures 11 15 0.01
Costs associated with transactions and productivity actions (176 ) (68 ) (132 ) (61 ) (0.11 ) (0.05 )
Impact of Argentine peso devaluation (98 ) (106 ) (0.09 )
Loss on early extinguishment of debt (8 ) (5 )
Uncertain tax position 44 0.04
Total certain items $ (1,837 ) $ 2,573 $ (1,154 ) $ 2,470 $ (0.95 ) $ 2.19
+ Dilutive effect of assumed preferred stock conversion into shares of common stock $ 0.07 $ 0.18
= Operating Results (Non-GAAP) (7) $ 1,121 $ 1,057 $ 0.99 $ 0.93
(1) Impact on "Income (Loss) Before Income Taxes."
(2) "Net Income (Loss) Available for The Dow Chemical Company Common Stockholders."
(3) "Earnings per common share - diluted."
(4) The assumed conversion of the Company's Cumulative Convertible Perpetual Preferred Stock, Series A ("Preferred Stock") into shares of the Company's common stock was excluded from the calculation of "Earnings per common share - diluted" (GAAP) for the three-month period ended December 31, 2016 and the certain items earnings per share impact for the three-month period ended December 31, 2015 because the effect of including them would have been antidilutive.
(5) For the three-month period ended December 31, 2016, an assumed conversion of the Company's Preferred Stock into shares of the Company's common stock was included in the calculation of "Operating earnings per common share - diluted" (Non-GAAP). For the three-month period ended December 31, 2015, an assumed conversion of the Company's Preferred Stock into shares of the Company's common stock was included in the calculation of "Earnings per common share - diluted" (GAAP) "and "Operating earnings per common share - diluted" (Non-GAAP).
(6) The Company used "Net Income Attributable to The Dow Chemical Company" when calculating "Earnings per common share - diluted" (GAAP) for the three-month period ended December 31, 2015, as it excludes quarterly preferred dividends of $85 million.
(7) "Operating earnings per common share - diluted" (Non-GAAP) for the three-month periods ended December 31, 2016 and December 31, 2015, excludes quarterly preferred dividends of $85 million.

The following table summarizes the impact of certain items recorded in the twelve-month periods ended December 31, 2016 and December 31, 2015:

Certain Items Impacting Results Pretax Impact (1) Net Income (2) EPS - Diluted (3) (4) (5)
Twelve Months Ended Twelve Months Ended Twelve Months Ended
In millions, except per share amounts (Unaudited) Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Reported U.S. GAAP Amounts (6) $ 3,978 $ 7,345 $ 3.52 $ 6.15
- Certain items:
Environmental charges $ (295 ) $ (205 ) (0.17 )
Charge for the termination of a terminal use agreement (117 ) (74 ) (0.06 )
Impact of Dow Corning ownership restructure 2,106 2,350 2.07
Asset impairments and related costs (144 ) (123 ) (0.11 )
Restructuring charges (454 ) (415 ) (308 ) (274 ) (0.27 ) (0.24 )
Asbestos-related charge (1,113 ) (701 ) (0.58 )
Joint venture actions (36 ) (26 ) (0.02 )
Implant liability adjustment 27 17 0.01
Charges related to AgroFresh (163 ) (103 ) (0.08 )
Urethane matters legal settlements (1,235 ) (778 ) (0.70 )
Gain on split-off of chlorine value chain 6 2,233 6 2,215 0.01 1.96
Gain on sale of MEGlobal 723 589 0.52
Gain on 2015 business divestitures 1,320 823 0.71
Gain on Univation step acquisition 349 351 0.30
Impact of Argentine peso devaluation (98 ) (106 ) (0.09 )
Loss on early extinguishment of debt (8 ) (5 )
Costs associated with transactions and productivity actions (544 ) (194 ) (434 ) (153 ) (0.38 ) (0.13 )
Uncertain tax position (13 ) (0.01 )
Total certain items $ (1,782 ) $ 3,730 $ (243 ) $ 3,291 $ (0.16 ) $ 2.90
+ Dilutive effect of assumed preferred stock conversion into shares of common stock $ 0.04 $ 0.22
= Operating Results (Non-GAAP) (7) $ 4,221 $ 4,054 $ 3.72 $ 3.47
(1) Impact on "Income Before Income Taxes."
(2) "Net Income Available for The Dow Chemical Company Common Stockholders."
(3) "Earnings per common share - diluted."
(4) The assumed conversion of the Company's Preferred Stock into shares of the Company's common stock was excluded from the calculation of "Earnings per common share - diluted" for the twelve-month period ended December 31, 2016 and the calculation of "Operating earnings per common share - diluted" (Non-GAAP) as well as the certain items earnings per share impact for the twelve-month period ended December 31, 2015 because the effect of including them would have been antidilutive.
(5) For the twelve-month period ended December 31, 2016, an assumed conversion of the Company's Preferred Stock into shares of the Company's common stock was included in the calculation of "Operating earnings per common share - diluted" (Non-GAAP). For the twelve-month period ended December 31, 2015, an assumed conversion of the Company's Preferred Stock into shares of the Company's common stock was included in the calculation of "Earnings per common share - diluted" (GAAP).
(6) The Company used "Net Income Attributable to The Dow Chemical Company" when calculating "Earnings per common share - diluted" (GAAP) for the twelve-month period ended December 31, 2015, as it excludes preferred dividends of $340 million.
(7) "Operating earnings per common share - diluted" (Non-GAAP) for the twelve-month period ended December 31, 2016, excludes preferred dividends of $340 million.

The following tables present U.S. GAAP and Operating share counts for the three- and twelve-month periods ended December 31, 2016 and December 31, 2015:

U.S. GAAP Share Count Three Months Ended Twelve Months Ended
In millions Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Weighted average common shares - basic (1) 1,106.2 1,105.4 1,108.1 1,130.1
Plus dilutive effect of options and awards (2) 16.7 15.1 14.5
Plus common shares from assumed conversion of preferred stock (3) 96.8 96.8
Weighted average common shares - diluted (2) 1,106.2 1,218.9 1,123.2 1,241.4
(1) On December 30, 2016, the Company converted 4 million shares of Preferred Stock into 96.8 million shares of the Company's common stock. In accordance with U.S. GAAP, the basic share count for the three- and twelve-month periods ended December 31, 2016 reflects a two-day averaging effect related to this conversion, or 2.1 million shares for the three-month period ended December 31, 2016 and .5 million shares for the twelve-month period ended December 31, 2016.
(2) For the three-month period ended December 31, 2016, the Company reported "Net Loss Available for The Dow Chemical Company Common Stockholders." In accordance with U.S. GAAP, "Weighted-average common shares outstanding - basic" was used in the calculation of "Earnings per common share - diluted."
(3) In accordance with U.S. GAAP, the assumed conversion of the Preferred Stock was considered antidilutive to the "Earnings per common share - diluted" calculation for the three- and twelve-month periods ended December 31, 2016.
Operating EPS Share Count (Non-GAAP) Three Months Ended Twelve Months Ended
In millions Dec 31, 2016 Dec 31, 2015 Dec 31, 2016 Dec 31, 2015
Weighted average common shares - basic (1) 1,106.2 1,105.4 1,108.1 1,130.1
Plus dilutive effect of options and awards (2) 15.9 16.7 15.1 14.5
Plus common shares from assumed conversion of preferred stock (3) 94.7 96.8 96.3
Weighted average common shares - diluted (Non-GAAP) 1,216.8 1,218.9 1,219.5 1,144.6
(1) On December 30, 2016, the Company converted 4 million shares of Preferred Stock into 96.8 million shares of the Company's common stock. In accordance with U.S. GAAP, the basic share count for the three- and twelve-month periods ended December 31, 2016 reflects a two-day averaging effect related to this conversion, or 2.1 million shares for the three-month period ended December 31, 2016 and .5 million shares for the twelve-month period ended December 31, 2016.
(2) The dilutive effect of options and awards was included in the "Operating earnings per common share - diluted" calculation for the three-month period ended December 31, 2016 as the Company had net income for this period on an operating basis (Non-GAAP).
(3) The assumed conversion of the Preferred Stock was considered dilutive to the "Operating earnings per common share - diluted" calculation for the three- and twelve-month periods ended December 31, 2016. As a result and in accordance with U.S. GAAP, the share count for the three-month period ended December 31, 2016 reflects a 90-day averaging effect, or 94.7 million shares. The share count for the twelve-month period ended December 31, 2016 reflects a 363-day averaging effect, or 96.3 million shares.

Results in the fourth quarter of 2016 were impacted by the following items:

Results in the fourth quarter of 2015 were impacted by the following items:

In addition to the items described above for the fourth quarter of 2016, results for the year ended December 31, 2016 were also impacted by the following items:

In addition to the items described above for the fourth quarter of 2015, results for the year ended December 31, 2015 were also impacted by the following items:

The Dow Chemical Company

Kyle Bandlow

+1 989 638 2417

[email protected]

Source: The Dow Chemical Company

Categories

Press Releases

Next Articles